Athletics directors at all ncaa member institutions perform the same tasks. group of answer choices

1. Herring SA, Kibler WB, Putukian M. Team physician consensus statement: 2013 update. Med Sci Sports Exerc 2013; 45: 1618– 22. [PubMed] [Google Scholar]

2. Kligfield P, Gettes LS, Bailey JJ, et al. Recommendations for the standardization and interpretation of the electrocardiogram; part I: the electrocardiogram and its technology. A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. J Am Coll Cardiol 2007; 49: 1109– 27. [PubMed] [Google Scholar]

3. Drezner J. ECG interpretation in athletes. BMJ Learning. Available at: http://learning.bmj.com/learning/course-intro/.html?courseId=10042239. Accessed March 24, 2016. [Google Scholar]

4. American Heart Association. Cardiac EMERGENCY RESPONSE PLAN. Available at:http://cpr.heart.org/AHAECC/CPRAndECC/Programs/CPRInSchools/UCM_477994_Cardiac-Emergency-Response-Plan.jsp. Accessed March 24, 2016. [Google Scholar]

5. Paffenbarger RS, Jr., Hyde RT, Wing AL, et al. A natural history of athleticism and cardiovascular health. JAMA 1984; 252: 491– 5. [PubMed] [Google Scholar]

6. Sarna S, Sahi T, Koskenvuo M, et al. Increased life expectancy of world class male athletes. Med Sci Sports Exerc 1993; 25: 237– 44. [PubMed] [Google Scholar]

7. Kujala UM, Sarna S, Kaprio J, et al. Hospital care in later life among former world-class Finnish athletes. JAMA 1996; 276: 216– 20. [PubMed] [Google Scholar]

8. Corrado D, Basso C, Rizzoli G, et al. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 2003; 42: 1959– 63. [PubMed] [Google Scholar]

9. Toresdahl BG, Rao AL, Harmon KG, et al. Incidence of sudden cardiac arrest in high school student athletes on school campus. Heart Rhythm 2014; 11: 1190– 4. [PubMed] [Google Scholar]

10. Maron BJ, Friedman RA, Kligfield P, et al. Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 2014; 64: 1479– 514. [PubMed] [Google Scholar]

11. Yankelson L, Sadeh B, Gershovitz L, et al. Life-threatening events during endurance sports: is heat stroke more prevalent than arrhythmic death? J Am Coll Cardiol 2014; 64: 463– 9. [PubMed] [Google Scholar]

12. Maron BJ, Haas TS, Murphy CJ, et al. Incidence and causes of sudden death in U.S. college athletes. J Am Coll Cardiol 2014; 63: 1636– 43. [PubMed] [Google Scholar]

13. Maron BJ, Winkel B, Tfelt-Hansen J. Perspectives on cardiovascular screening. JAMA 2015; 313: 31– 2. [PubMed] [Google Scholar]

14. Maron BJ, Winkel B, Tfelt-Hansen J. Cardiovascular screening for young athletes—reply. JAMA 2015; 313: 1674– 5. [PubMed] [Google Scholar]

15. Harmon KG, Asif IM, Klossner D, et al. Incidence of sudden cardiac death in National Collegiate Athletic Association athletes. Circulation 2011; 123: 1594– 600. [PubMed] [Google Scholar]

16. Harmon KG, Drezner JA. Cardiovascular screening for young athletes. JAMA 2015; 313: 1673– 4. [PubMed] [Google Scholar]

17. Harmon KG, Asif IM, Maleszewski JJ, et al. Incidence, cause, and comparative frequency of sudden cardiac death in National Collegiate Athletic Association athletes: a decade in review. Circulation 2015; 132: 10– 9. [PMC free article] [PubMed] [Google Scholar]

18. Kucera K. Catastrophic sports injury surveillance for fatal cardiac events among collegiate athletes, 1982/93 to 2012/13: report prepared for NCAA Cardiac Summit, September 16, 2014. Chapel Hill, NC: National Center for Catastrophic Sport Injury Research, The University of North Carolina at Chapel Hill, 2014. [Google Scholar]

19. Parsons J. editor 2014-15 NCAA Sports Medicine Handbook. 25th edition. Indianapolis, IN: The National Collegiate Athletic Association, 2014. [Google Scholar]

20. Burnsed B. New guidelines aim to improve student-athlete safety. NCAA Media Center. July 8, 2014. Available at: http://www.ncaa.org/about/resources/media-center/news/new-guidelines-aim-improve-student-athlete-safety. Accessed March 23, 2016. [Google Scholar]

21. American Academy of Family Physicians, American Academy of Pediatrics, American College of Sports Medicine, American Medical Society for Sports Medicine. Preparticipation Physical Evaluation. Fourth Edition. Elk Grove Village, IL: American Academy of Pediatrics, 2010. [Google Scholar]

22. Maron BJ, Douglas PS, Graham TP, et al. Task force 1: preparticipation screening and diagnosis of cardiovascular disease in athletes. J Am Coll Cardiol 2005; 45: 1322– 6. [PubMed] [Google Scholar]

23. Maron BJ, Levine BD, Washington RL, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 2: preparticipation screening for cardiovascular disease in competitive athletes: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015; 66: 2356– 61. [PubMed] [Google Scholar]

24. Ljungqvist A, Jenoure P, Engebretsen L, et al. The International Olympic Committee (IOC) consensus statement on periodic health evaluation of elite athletes March 2009. Br J Sports Med 2009; 43: 631– 43. [PubMed] [Google Scholar]

25. Corrado D, Pelliccia A. Bj0rnstad HH, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Eur Heart J 2005; 26: 516– 24. [PubMed] [Google Scholar]

26. Maron BJ, Thompson PD, Puffer JC, et al. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation 1996; 94: 850– 6. [PubMed] [Google Scholar]

27. Maron BJ, Zipes DP, Kovacs RJ. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015; 66: 2343– 9. [PubMed] [Google Scholar]

28. Maron BJ, Thompson PD, Ackerman MJ, et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2007; 115: 1643– 55. [PubMed] [Google Scholar]

29. Mancia G, Kjeldsen SE, Zappe DH, et al. Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial. Eur Heart J 2016; 37: 955– 64. [PubMed] [Google Scholar]

30. Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129: S76– 99. [PubMed] [Google Scholar]

31. Estes NA, III, Kovacs RJ, Baggish AL, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 11: drugs and performance-enhancing substances: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015; 66: 2429– 33. [PubMed] [Google Scholar]

32. Maron BJ, Harris KM, Thompson PD, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 14: sickle cell trait: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015; 66: 2444– 6. [PubMed] [Google Scholar]

33. Dunn TP, Pickham D, Aggarwal S, et al. Limitations of current AHA guidelines and proposal of new guidelines for the preparticipation examination of athletes. Clin J Sport Med 2015; 25: 472– 7. [PubMed] [Google Scholar]

34. Drezner JA, Prutkin JM, Harmon KG, et al. Cardiovascular screening in college athletes. J Am Coll Cardiol 2015; 65: 2353– 5. [PubMed] [Google Scholar]

35. Fudge J, Harmon KG, Owens DS, et al. Cardiovascular screening in adolescents and young adults: a prospective study comparing the Preparticipation Physical Evaluation Monograph 4th Edition and ECG. Br J Sports Med 2014; 48: 1172– 8. [PMC free article] [PubMed] [Google Scholar]

36. Dvorak J, Grimm K, Schmied C, et al. Development and implementation of a standardized precompetition medical assessment of international elite football players-2006 FIFA World Cup Germany. Clin J Sport Med 2009; 19: 316– 21. [PubMed] [Google Scholar]

37. Harmon KG, Zigman M, Drezner JA. The effectiveness of screening history, physical exam, and ECG to detect potentially lethal cardiac disorders in athletes: a systematic review/metaanalysis. J Electrocardiol 2015; 48: 329– 38. [PubMed] [Google Scholar]

38. Maron BJ, Shirani J, Poliac LC, et al. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 1996; 276: 199– 204. [PubMed] [Google Scholar]

39. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J 2010; 31: 806– 14. [PMC free article] [PubMed] [Google Scholar]

40. Campbell RM, Berger S, Drezner J. Sudden cardiac arrest in children and young athletes: the importance of a detailed personal and family history in the pre-participation evaluation. Br J Sports Med 2009; 43: 336– 41. [PubMed] [Google Scholar]

41. Drezner JA, Ackerman MJ, Cannon BC, et al. Abnormal electrocardiographic findings in athletes: recognising changes suggestive of primary electrical disease. Br J Sports Med 2013; 47: 153– 67. [PubMed] [Google Scholar]

42. Basso C, Maron BJ, Corrado D, et al. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol 2000; 35: 1493– 501. [PubMed] [Google Scholar]

43. Berte B, Duytschaever M, Elices J, et al. Variability in interpretation of the electrocardiogram in young athletes: an unrecognized obstacle for electrocardiogram-based screening protocols. Europace 2015; 17: 1435– 40. [PubMed] [Google Scholar]

44. Sharma S, Dhutia H. Variation of electrocardiogram interpretation: yet another contributor to the Achilles heel of pre-participation electrocardiographic programmes in athletes. Europace 2015; 17: 1323– 4. [PubMed] [Google Scholar]

45. Drezner JA, Ackerman MJ, Anderson J, et al. Electrocardiographic interpretation in athletes: the 'Seattle Criteria.' Br J Sports Med 2013; 47: 122– 4. [PubMed] [Google Scholar]

46. Brosnan M, La Gerche A, Kalman J, et al. The Seattle Criteria increase the specificity of preparticipation ECG screening among elite athletes. Br J Sports Med 2014; 48: 1144– 50. [PubMed] [Google Scholar]

47. Baggish AL, Hutter AM, Jr., Wang F, et al. Cardiovascular screening in college athletes with and without electrocardiography: a cross-sectional study. Ann Intern Med 2010; 152: 269– 75. [PubMed] [Google Scholar]

48. Wasfy MM, DeLuca J, Wang F, et al. ECG findings in competitive rowers: normative data and the prevalence of abnormalities using contemporary screening recommendations. Br J Sports Med 2015; 49: 200– 6. [PubMed] [Google Scholar]

49. Drezner J. Electrocardiographic screening in NCAA athletes: a 2-year multicenter feasibility trial. Paper presented at: NCAA Cardiac Summit; September 16, 2014; Indianapolis, IN. [Google Scholar]

50. Graham R, McCoy MA, Schultz AM. Committee on the Treatment of Cardiac Arrest: Current Status and Future Directions; Board on Health Sciences Policy; Institute of Medicine. Strategies to Improve Cardiac Arrest Survival: A Time to Act. Washington, DC: The National Academies Press, 2015. [Google Scholar]

51. Myerburg RJ, Ullmann SG. Alternative research funding to improve clinical outcomes: model of prediction and prevention of sudden cardiac death. Circ Arrhythm Electrophysiol 2015; 8: 492– 8. [PubMed] [Google Scholar]

52. Maron BJ, Udelson JE, Bonow RO, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015; 66: 2362– 71. [PubMed] [Google Scholar]

53. Van Hare GF, Ackerman MJ, Evangelista JA, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 4: congenital heart disease: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015; 66: 2372– 84. [PubMed] [Google Scholar]

54. Bonow RO, Nishimura RA, Thompson PD, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 5: valvular heart disease: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015; 66: 2385– 92. [PubMed] [Google Scholar]

55. Black HR, Sica D, Ferdinand K, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 6: hypertension: a scientific statement from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 2015; 66: 2393– 7. [PubMed] [Google Scholar]

56. Braverman AC, Harris KM, Kovacs RJ, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 7: aortic diseases, including marfan syndrome: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015; 66: 2398– 405. [PubMed] [Google Scholar]

57. Thompson PD, Myerburg RJ, Levine BD, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 8: coronary artery disease: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015; 66: 2406– 11. [PubMed] [Google Scholar]

58. Zipes DP, Link MS, , Ackerman MJ, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 9: arrhythmias and conduction defects: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015; 66: 2412– 23. [PubMed] [Google Scholar]

59. Ackerman MJ, Zipes DP, Kovacs RJ, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 10: the cardiac channelopathies: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015; 66: 2424– 8. [PubMed] [Google Scholar]

60. Link MS, , Estes NA, III, Maron BJ. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 13: commotio cordis: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015; 66: 2439– 43. [PubMed] [Google Scholar]

61. Drezner JA, Courson RW, Roberts WO, et al. Inter-Association Task Force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement. J Athl Train 2007; 42: 143– 58. [PMC free article] [PubMed] [Google Scholar]

62. Link MS, , Myerburg RJ, Estes NA., III Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 12: emergency action plans, resuscitation, cardiopulmonary resuscitation, and automated external defibrillators: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015; 66: 2434– 8. [PubMed] [Google Scholar]

63. Drezner JA, Rao AL, Heistand J, et al. Effectiveness of emergency response planning for sudden cardiac arrest in United States high schools with automated external defibrillators. Circulation 2009; 120: 518– 25. [PubMed] [Google Scholar]

64. Drezner JA, Rogers KJ. Sudden cardiac arrest in intercollegiate athletes: detailed analysis and outcomes of resuscitation in nine cases. Heart Rhythm 2006; 3: 755– 9. [PubMed] [Google Scholar]

65. Vernuccio F, Grutta G, Fazio G. [Sudden cardiac death in athletes: is it always not preventable?]. Recenti Prog Med 2014; 105: 410– 4. [PubMed] [Google Scholar]

66. Larsen MP, Eisenberg MS, , Cummins RO, et al. Predicting survival from out-of-hospital cardiac arrest: a graphic model. Ann Emerg Med 1993; 22: 1652– 8. [PubMed] [Google Scholar]

67. Drezner JA, Toresdahl BG, Rao AL, et al. Outcomes from sudden cardiac arrest in US high schools: a 2-year prospective study from the National Registry for AED Use in Sports. Br J Sports Med 2013; 47: 1179– 83. [PubMed] [Google Scholar]

68. Bhanji F, Donoghue AJ, Wolff MS, , et al. Part 14: education: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2015; 132: S561– 73. [PubMed] [Google Scholar]

69. The National Collegiate Athletic Association. Catastrophic injury reporting requirement starts Aug. 1. NCAA Media Center. July 31, 2014. Available at: http://www.ncaa.org/about/resources/media-center/news/catastrophic-injury-reportingrequirement-starts-aug-1. Accessed March 23, 2016. [Google Scholar]

70. Fuller CM, McNulty CM, Spring DA, et al. Prospective screening of 5,615 high school athletes for risk of sudden cardiac death. Med Sci Sports Exerc 1997; 29: 1131– 8. [PubMed] [Google Scholar]

71. Wilson MG, Basavarajaiah S, Whyte GP, et al. Efficacy of personal symptom and family history questionnaires when screening for inherited cardiac pathologies: the role of electrocardiography. Br J Sports Med 2008; 42: 207– 11. [PubMed] [Google Scholar]

72. Bessem B, Groot FP, Nieuwland W. The Lausanne recommendations: a Dutch experience. Br J Sports Med 2009; 43: 708– 15. [PubMed] [Google Scholar]

73. Hevia AC, Fernández MM, Palacio JMA, et al. ECG as a part of the preparticipation screening programme: an old and still present international dilemma. Br J Sports Med 2011; 45: 776– 9. [PubMed] [Google Scholar]

74. Magalski A, McCoy M, Zabel M, et al. Cardiovascular screening with electrocardiography and echocardiography in collegiate athletes. Am J Med 2011; 124: 511– 8. [PubMed] [Google Scholar]

75. Price DE, McWilliams A, Asif IM, et al. Electrocardiography-inclusive screening strategies for detection of cardiovascular abnormalities in high school athletes. Heart Rhythm 2014; 11: 442– 9. [PubMed] [Google Scholar]

76. Menafoglio A, Di Valentino M, Segatto JM, et al. Costs and yield of a 15-month preparticipation cardiovascular examination with ECG in 1070 young athletes in Switzerland: implications for routine ECG screening. Br J Sports Med 2014; 48: 1157– 61. [PubMed] [Google Scholar]